White, H D, Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Erglis, A, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Lopes, R D, Mahaffey, K W, Moryusef, A, Pordy, R, Roe, M T, Sritara, P, Tricoci, P, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Davidsen, F & Videbaek, L 2019, ' Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial ', European Heart Journal, vol. 40, no. 33, pp. 2801-2809 . https://doi.org/10.1093/eurheartj/ehz299 European Heart Journal, 40(33), 2801-2809. OXFORD UNIV PRESS European Heart Journal Volume 40 Issue 33 European Heart Journal, 40(33), 2801-2809. Oxford University Press European heart journal EUROPEAN HEART JOURNAL r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname European heart journal 40(33), 2801-2809 (2019). doi:10.1093/eurheartj/ehz299 special issue: "Focus Issue on LIPIDS"